Calcium Malate 200
Natural health product licensed in Canada
- Other names
- Calcium, Calcium Malate Bisglycinate
- Licence holder
- Codeco Nutrition Inc.
- NPN or DIN-HM
- 80088649
- Status
- Active licence
- Licence date
- 10 October 2018
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Calcium Source : Diglycinate de calcium | 200 milligramme | Not calculated |
| Calcium Source : Malate de dicalcium | 200 milligramme | Not calculated |
Non-medicinal ingredients
Hypromellose, Cellulose microcristalline, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | minimum: 1 year ; maximum: 9 years | minimum: 1 Capsule ; maximum: 2 Capsule | minimum: 1 Tous les jours ; maximum: 3 Tous les jours |
| Adultes et adolescents | minimum: 12 years | minimum: 1 Capsule ; maximum: 2 Capsule | minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
Uses authorised in Canada
A factor in the maintenance of good health. Adequate calcium (and vitamin D) (throughout life) as part of a healthy diet, (along with physical activity) may help prevent bone loss/osteoporosis (in peri- and postmenopausal women) (in later life). Helps in the development and maintenance of bones and teeth especially in childhood, adolescence and young adulthood. Adequate calcium (and vitamin D) (throughout life) as part of a healthy diet, (along with physical activity) may reduce the risk of developing osteoporosis (in peri- and postmenopausal women) (in later life). Helps in the development and maintenance of bones and teeth.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80088649
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.